A Prospective, Double-Blinded, Randomized Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2019
Price : $35 *
At a glance
- Drugs Fibrin (Primary)
- Indications Wounds
- Focus Adverse reactions; Therapeutic Use
- 06 Feb 2019 Status changed from recruiting to completed.
- 14 Sep 2014 Planned End Date changed from 1 Sep 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 14 Sep 2014 Planned primary completion date changed from 1 Jul 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.